Several findings have supported the role of the RTK FMS-Related Tyrosine Kinase 4, FLT4, also called VEGFR3 (Vascular Endothelial Growth Factor Receptor- 3) and its ligand, VEGFC (Vascular Endothelial Growth Factor-C), in cancer progression [30, 31]. Here, FLT4 is linked to cancer.